Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Carisma Therapeutics Inc (CARM)

Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Carisma Therapeutics to Present at Upcoming Investor Conferences PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Announces Latest Data from Phase 1 Clinical Trial of CT-0508 at 8th Annual CAR-TCR Summit PR Newswire - Fri Sep 1, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in September 2023 PR Newswire - Thu Aug 24, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics Announces First Patient Dosed in Phase 1 Study of CT-0508 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HER2 Overexpressing Solid Tumors PR Newswire - Wed Jun 28, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to be Added to Russell 2000®, Russell 3000® and Russell Microcap® Indexes PR Newswire - Mon Jun 26, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics Appoints Eric Siegel as General Counsel and Corporate Secretary and Terry Shields as Senior Vice President of Human Resources PR Newswire - Wed Jun 14, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma Therapeutics" or the "Company"), a clinical stage biopharmaceutical company focused on...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to Present at Upcoming Investor Conferences in June 2023 PR Newswire - Mon Jun 5, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023 PR Newswire - Tue May 30, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to Present at the JMP Securities Life Sciences Conference PR Newswire - Mon May 8, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...

CARM : 1.3600 (-5.56%)
Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in May 2023 PR Newswire - Fri May 5, 2023

/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing...

CARM : 1.3600 (-5.56%)

Barchart Exclusives

Large Unusual Activity in Tesla Put Options Dominates the Options Market Today Barchart - 1 hour ago
Today there is large, unusual activity in Tesla options. This is almost certainly due to the recent rise in TSLA stock. The puts highlight investors' concerns about Tesla stock, but they also present good income plays. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot